AI MARKET SCANNING

$CRIS

Curis Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP0.37%
MAX GAP RECORD12.78%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $CRIS

EXECUTIONS1 LOGS
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
2026-08-11QUANT ALGOBUY x5$•••.•• → $•••.••19m🔒 ENCRYPTED+0.66%
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY5.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $CRIS

AI REPORT
Aug 17

Adapting Your Portfolio Strategy in Volatile Markets

AnalysisMarkets have shown heightened volatility recently, presenting both challenges and opportunities for investors. In this post, we’ll explore…
VIEW REPORT_
AI REPORT
Aug 14

Navigating Market Uncertainty with a Robust Portfolio Strategy

Analysis Markets are navigating a landscape of heightened volatility, driven by macroeconomic factors and shifting investor sentiment. The…
VIEW REPORT_